shortness of breath; chest pain; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority-web. the reporter is the patient. regulatory number: ie-hpra-2022-093041 (regulatory authority). other case identifier(s): ie-hpra-cvarr2022021325795 (regulatory authority). a 18 year-old male patient received bnt162b2 (comirnaty), administration date 10feb2022 (lot number: acb9330) as dose number unknown (booster) single for covid-19 immunisation. the patient had no relevant medical history. there were no concomitant medications. vaccination history included: covid-19 vaccine (dose number unknown , manufacturer unknown), for covid-19 immunisation. the following information was reported: dyspnoea (medically significant) with onset 12feb2022, outcome "not recovered", described as "shortness of breath"; chest pain (medically significant) with onset 12feb2022, outcome "not recovered", described as "chest pain". the events "shortness of breath" and "chest pain" were evaluated at the emergency room visit. therapeutic measures were taken as a result of dyspnoea, chest pain was prescribed antihistamines (further details not provided). at the time of reporting, the patient's symptoms were continuing. no follow-up attempts are possible. no further information is expected